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INTRODUCTION
Hepatitis E virus (HEV) infection is one of the commonest emerging diseases. 
It has affected 20 million people with 3.4 million symptomatic cases worldwide. 
Approximately 56,600 people have died and 3,000 stillbirths have occurred 
worldwide in 2005 due to HEV-related conditions.[1] HEV genotypes 1 and 2 are 
endemic in developing countries, and the major route of transmission is faecal-oral 
usually through contaminated water. HEV-1 and HEV-2 usually cause epidemic 
hepatitis that occurs sporadically throughout the year. Clinical presentation 
varies widely from asymptomatic or non-specific symptoms through severe life-
threatening fulminant hepatitis and acute liver failure. Pregnant women especially 
during the third trimester have increased risk with subsequent development of 
adverse foeto-maternal outcomes (fulminant hepatic failure, preterm delivery, 
low birth weight and foetal mortality.[2] Also, other co-infections such as Human 
Immunodeficiency Virus (HIV) and Hepatitis B virus (HBV) have been correlated 
with increased frequency and exacerbated effects of HEV infection.[3]
In Africa HEV seroprevalence varies greatly from 0%-94% in the general population 
and outbreaks, with the case fatality rates of 17.8% and 42.1% in the general 
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population and pregnant women respectively. The largest 
outbreak in Africa was reported in Uganda in 2007, which 
led to an attack rate of 25% of the population.[4] 
Tanzania, one of the most resource-constrained countries 
in Africa, has poor foeto-maternal outcomes and a high 
burden of HIV and HBV infections. Clear information on 
the actual extent of HEV infection is needed. In this study 
we reviewed the available literature on HEV infection to 
determine the current situation, and to identify future 
areas of study.
METHOD
All English full articles or abstracts that reported on HEV 
in Tanzania were reviewed. We searched PubMed, Web 
of Science and Scopus databases for the article titles and/
or abstracts published from inception to 30 September 
2019. There were no initial exclusion criteria, as we aimed 
to review all available articles related to HEV.  However 
certain publications were excluded later as indicated in 
Figure 1. The following search term combinations were 
used: (“hepatitis E” or “HEV” or “non-a” or “non-b” or 
“viral hepatitis” or “enteric hepatitis”) AND (“Tanzania” or 
“Zanzibar” or “Arusha” or “Dar es Salaam” or “Dodoma” 
or “Geita” or “Iringa” or “Kagera” or “Katavi” or “Kigoma” 
or Kilimanjaro” or “Lindi” or “Manyara” or “Mara” or 
“Mbeya” or “Morogoro” or “Mtwara” or “Mwanza” 
or “Njombe’ or “Pemba” or “Pwani” or “Rukwa” or 
“Ruvuma” or “Shinyanga” or “Simiyu” or “Singida” or 
“Tabora” or Tanga” or “Unguja”). The latter is a list 
of all administrative regions in Tanzania.  The relevant 
references from obtained articles were also reviewed. Gray 
literatures were also searched in the websites of Tanzania 
Ministry of Health, Community Development, Gender, 
Elderly and Children[5], Tanzania National Bureau of 
Statistics [6], World Health Organization’s country office 
[7] and Google search engine.
A total of 127 studies were identified after removing the 
duplicates; 64 from PubMed, 49 from Web of Science, 
and 13 from Scopus and one webpage. Out of these, we 
excluded 121 articles mainly because they did not contain 
data on HEV; and so, four studies and one webpage report 
remained for qualitative synthesis (Figure 1). 
RESULTS 
Epidemiology of HEV
There was only one study assessing HEV prevalence in the 
general population of Dar es Salaam in 1998. In this study 
one 26-year old woman out of 403 healthy volunteers 
(0.2%) was found to be seropositive for HEV. [8] Another 
study, in women of childbearing age (15-45 years) in a 
rural population of Moshi, in the northern part of the 
country, reported the HEV seroprevalence of 6.6%. In this 
study there was a trend, albeit not statistically significant, 
of increasing rates of HEV positivity in women aged 35 
years and older compared with the younger group (9% 
vs. 5%). Other socio-demographic factors including 
residence and number of children 
were not associated with HEV 
infection. [9] Menendez et al [10] 
reported that no evidence of 
HEV infection in 180 pregnant 
women tested during the third-
trimester of pregnancy in Ifakara, 
in southern Tanzania. A more 
recent study in 2018 has shown a 
higher HEV seroprevalence of 8% 
among HIV-infected pregnant 
women in the third trimester and 
at 9-months post-partum in the 
urban population of Tanga City. 
In this follow-up study, the annual 
HEV incidence rate was 1% 
(confidence interval 0.2%-3.4%). 
The median ages of HEV infected 
and uninfected groups were 28.0 
(IQR 24-31) years and 28.5 
(IQR 24-30) years respectively 
(p>0.05). The gestation age and 
CD4 counts were comparable 
between the two groups.[11] More 
details of these studies are in Table 
1.
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Figure 1. Flow diagram of the literature search and selection process.
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HEV outbreaks
One HEV outbreak was reported in 2013 in Buhingwe 
Kigoma, the western region of Tanzania.  Six hundred and 
ninety patients were affected, most (61%) were children 
aged less than 15 years,; 54% were females.  Most of the 
patients presented with general features: headache, fever, 
abdominal pain, general malaise, loss of appetite and 
vomiting. Jaundice and diarrhoea were rarely reported. 
The pregnancy state was not reported and there were no 
recorded deaths. In this outbreak, only 49 samples were 
actually tested, of which 14 were confirmed positive.[12]
DISCUSSION
High rates of HEV seroprevalence in the general population 
have been reported in neighbouring countries: Uganda 
(47.7%)[13], Zambia (42%)[14] and Kenya (18%).[4] We 
have identified one study[8], which reported only one case 
of HEV infection in the general Tanzanian population 
and a few other studies exclusively from female subjects. [9, 
10, 11] These provide insufficient data to accurately represent 
the situation in Tanzania. This knowledge gap might arise 
from  a low rate of routine HEV testing  because of poor 
clinical awareness, unavailability of the resources and the 
tendency of diagnosing and treating for clinical malaria 
the patients that present with non-specific symptoms.[15] 
It is likely that significant HEV infection rates do occur in 
Tanzania given the recorded higher rates in neighbouring 
countries. The maternal complications associated with 
HEV infection cannot be neglected.  Hence there is a 
need for updated information on the status and clinical 
presentations of the disease particularly in high-risk 
populations such as pregnant women. Also, adequate 
access and testing of these subjects should be advocated.
It is not uncommon for HEV outbreaks to occur in 
displaced communities and refugee camps due to poor 
hygienic conditions. Uganda and Kenya, on the northern 
border of Tanzania, have had major HEV outbreaks 
affecting about 14,000 people with fatality rates of 6.6% 
in the general population and 77.7% in pregnant women. 
[4]  In both of these outbreaks, water contamination 
and person-to-person contact were the major sources 
of infection. Even though the Tanzanian experience 
in 2013 [13] was less devastating, vulnerability to more 
critical incidents should not be underrated. Therefore 
comprehensive health education on the improvement 
of general hygienic measures for patients presenting 
with general symptoms, and high- risk groups would 
be beneficial to reduce transmission. Also, an improved 
case detection in this population will lead to a better and 
timely supportive care.
CONCLUSION
Despite the indicators for its endemicity, our study 
suggests that the reported rates of HEV in Tanzania are 
considerably lower than neighbouring countries. This is 
probably due to poor clinical awareness in the presence 
of non-specific symptoms. The risk of misdiagnosis is 
increased with consequent inappropriate management. 
Thus, more studies in different population groups are 
required to provide the baseline status of the disease 
and to hasten the establishment and implementation of 
evidence-based control policies, which are currently not 
available.
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